Related Experiment Videos
Successful immunization against experimental allergic encephalomyelitis with myelin basic protein-sensitized
Neurochemical Research
|June 1, 1981
Summary
Antibodies from lymphocytes sensitized to myelin basic protein (MBP) can prevent and suppress experimental allergic encephalomyelitis (EAE). This antibody-mediated immunity inhibits delayed type hypersensitivity, offering a novel therapeutic approach.
Area of Science:
- Immunology
- Neuroscience
- Autoimmune Diseases
Background:
- Experimental allergic encephalomyelitis (EAE) is a model for demyelinating diseases like multiple sclerosis.
- Understanding the mechanisms of EAE induction and suppression is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the role of lymphocytes and antibodies in preventing and suppressing EAE.
- To determine if cell-mediated immunity or antibody production is the primary mechanism of protection.
Main Methods:
- Rats, guinea pigs, and rabbits were immunized with allogeneic lymphocytes sensitized to myelin basic protein (MBP).
- Unresponsiveness was assessed following an encephalitogenic challenge with MBP.
- Immunoglobulin-G (IgG) was isolated from protected donors and transferred to naive recipients.
Main Results:
- Immunization with allogeneic, MBP-sensitized lymphocytes prevented and suppressed EAE in multiple species.
- A time lapse between immunization and challenge was necessary for protective immunity.
- Transferred IgG from protected donors conferred unresponsiveness, and recipients failed to develop cell-mediated immunity.
Conclusions:
- Antibodies, specifically IgG, mediate the prevention and suppression of EAE.
- This antibody-mediated suppression inhibits the development of delayed type hypersensitivity to MBP.
- Findings suggest a potential therapeutic strategy for EAE and related autoimmune disorders.